Andrew C. Parrott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew C. Parrott has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Luke A. Downey
Centre for Human Psychopharmacology Swinburne University of Technology Melbourne Australia
6 shared publications - Lynn Twarog Singer
Department of Population and Quantitative Health Sciences, Case Western Reserve University, 1090 Euclid Avenue, Cleveland, OH 44106, United States
3 shared publications - Andrew Scholey
Swinburne University
2 shared publications - Derek G. Moore
Institute for Research in Child Development, School of Psychology, University of East London, London, UK
2 shared publications - Jacqui Rodgers
Newcastle University, Newcastle upon Tyne, UK
2 shared publications - John J.D. Turner
Department of Psychological Sciences, University of East London, United Kingdom
2 shared publications
Latest Publications
- Open Access
- 13 March 2018
- Published by MDPI AG in Brain Sciences
- Vol. 8 (3) , 43
Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs
Many novel psychoactive substances (NPS) have entered the recreational drug scene in recent years, yet the problems they cause are similar to those found with established drugs. This article will debate the psychobiological effects of these newer and more traditional substances. It will show how they disrupt the same core psychobiological functions, so damaging well-being in similar ways. Every psychoactive drug causes mood states to fluctuate. Users feel better on-drug, then feel worse off-drug. The strength of these mood fluctuations is closely related to their addiction potential. Cyclical changes can occur with many other core psychobiological functions, such as information processing and psychomotor speed. Hence the list of drug-related impairments can include: homeostatic imbalance, HPA axis disruption, increased stress, altered sleep patterns, neurohormonal changes, modified brain rhythms, neurocognitive impairments, and greater psychiatric vulnerability. Similar patterns of deficit are found with older drugs such as cocaine, nicotine and cannabis, and newer substances such as 3,4-methylenedioxymethamphetamine (MDMA), mephedrone and spice. All psychoactive drugs damage human well-being through similar basic neuropsychobiological mechanisms.
- 13 March 2018
- Published by MDPI AG in Brain Sciences
- Vol. 8 (3) , 43
Open AccessMood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs
Many novel psychoactive substances (NPS) have entered the recreational drug scene in recent years, yet the problems they cause are similar to those found with established drugs. This article will debate the psychobiological effects of these newer and more traditional substances. It will show how they disrupt the same core psychobiological functions, so damaging well-being in similar ways. Every psychoactive drug causes mood states to fluctuate. Users feel better on-drug, then feel worse off-drug. The strength of these mood fluctuations is closely related to their addiction potential. Cyclical changes can occur with many other core psychobiological functions, such as information processing and psychomotor speed. Hence the list of drug-related impairments can include: homeostatic imbalance, HPA axis disruption, increased stress, altered sleep patterns, neurohormonal changes, modified brain rhythms, neurocognitive impairments, and greater psychiatric vulnerability. Similar patterns of deficit are found with older drugs such as cocaine, nicotine and cannabis, and newer substances such as 3,4-methylenedioxymethamphetamine (MDMA), mephedrone and spice. All psychoactive drugs damage human well-being through similar basic neuropsychobiological mechanisms.
- 1 July 2017
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 81, 159
Psychoactive drug influences on hair cortisol
- 1 July 2017
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 81, 159
Psychoactive drug influences on hair cortisol
- 29 June 2017
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (8) , 959-966
Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects
Aims: The purpose of this article is to debate current understandings about the psychobiological effects of recreational 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy’), and recommend theoretically-driven topics for future research. Methods: Recent empirical findings, especially those from novel topic areas were reviewed. Potential causes for the high variance often found in group findings were also examined. Results and conclusions: The first empirical reports into psychobiological and psychiatric aspects from the early 1990s concluded that regular users demonstrated some selective psychobiological deficits, for instance worse declarative memory, or heightened depression. More recent research has covered a far wider range of psychobiological functions, and deficits have emerged in aspects of vision, higher cognitive skill, neurohormonal functioning, and foetal developmental outcomes. However, variance levels are often high, indicating that while some recreational users develop problems, others are less affected. Potential reasons for this high variance are debated. An explanatory model based on multi-factorial causation is then proposed. Future directions: A number of theoretically driven research topics are suggested, in order to empirically investigate the potential causes for these diverse psychobiological deficits. Future neuroimaging studies should study the practical implications of any serotonergic and/or neurohormonal changes, using a wide range of functional measures.
- 29 June 2017
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 31 (8) , 959-966
Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects
Aims: The purpose of this article is to debate current understandings about the psychobiological effects of recreational 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy’), and recommend theoretically-driven topics for future research. Methods: Recent empirical findings, especially those from novel topic areas were reviewed. Potential causes for the high variance often found in group findings were also examined. Results and conclusions: The first empirical reports into psychobiological and psychiatric aspects from the early 1990s concluded that regular users demonstrated some selective psychobiological deficits, for instance worse declarative memory, or heightened depression. More recent research has covered a far wider range of psychobiological functions, and deficits have emerged in aspects of vision, higher cognitive skill, neurohormonal functioning, and foetal developmental outcomes. However, variance levels are often high, indicating that while some recreational users develop problems, others are less affected. Potential reasons for this high variance are debated. An explanatory model based on multi-factorial causation is then proposed. Future directions: A number of theoretically driven research topics are suggested, in order to empirically investigate the potential causes for these diverse psychobiological deficits. Future neuroimaging studies should study the practical implications of any serotonergic and/or neurohormonal changes, using a wide range of functional measures.
- 30 May 2017
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 32 (3)
Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects
Aims: Recreational drugs are taken for their positive mood effects, yet their regular usage damages well‐being. The psychobiological mechanisms underlying these damaging effects will be debated.Methods: The empirical literature on recreational cannabinoids and stimulant drugs is reviewed. A theoretical explanation for how they cause similar types of damage is outlined.Results: All psychoactive drugs cause moods and psychological states to fluctuate. The acute mood gains underlie their recreational usage, while the mood deficits on withdrawal explain their addictiveness. Cyclical mood changes are found with every central nervous system stimulant and also occur with cannabis. These mood state changes provide a surface index for more profound psychobiological fluctuations. Homeostatic balance is altered, with repetitive disturbances of the hypothalamic–pituitary–adrenal axis, and disrupted cortisol‐neurohormonal secretions. Hence, these drugs cause increased stress, disturbed sleep, neurocognitive impairments, altered brain activity, and psychiatric vulnerability. Equivalent deficits occur with novel psychoactive stimulants such as mephedrone and artificial “spice” cannabinoids. These psychobiological fluctuations underlie drug dependency and make cessation difficult. Psychobiological stability and homeostatic balance are optimally restored by quitting psychoactive drugs.Conclusions: Recreational stimulants such as cocaine or MDMA (3.4‐methylenedioxymethamphetamine) and sedative drugs such as cannabis damage human homeostasis and well‐being through similar core psychobiological mechanisms.
- 30 May 2017
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 32 (3)
Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects
Aims: Recreational drugs are taken for their positive mood effects, yet their regular usage damages well‐being. The psychobiological mechanisms underlying these damaging effects will be debated.Methods: The empirical literature on recreational cannabinoids and stimulant drugs is reviewed. A theoretical explanation for how they cause similar types of damage is outlined.Results: All psychoactive drugs cause moods and psychological states to fluctuate. The acute mood gains underlie their recreational usage, while the mood deficits on withdrawal explain their addictiveness. Cyclical mood changes are found with every central nervous system stimulant and also occur with cannabis. These mood state changes provide a surface index for more profound psychobiological fluctuations. Homeostatic balance is altered, with repetitive disturbances of the hypothalamic–pituitary–adrenal axis, and disrupted cortisol‐neurohormonal secretions. Hence, these drugs cause increased stress, disturbed sleep, neurocognitive impairments, altered brain activity, and psychiatric vulnerability. Equivalent deficits occur with novel psychoactive stimulants such as mephedrone and artificial “spice” cannabinoids. These psychobiological fluctuations underlie drug dependency and make cessation difficult. Psychobiological stability and homeostatic balance are optimally restored by quitting psychoactive drugs.Conclusions: Recreational stimulants such as cocaine or MDMA (3.4‐methylenedioxymethamphetamine) and sedative drugs such as cannabis damage human homeostasis and well‐being through similar core psychobiological mechanisms.
- 19 April 2017
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 57 (10) , 1330-1337
Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants
The recreational use of various stimulant drugs has been implicated in the development of movement disorders through dysregulation of the dopaminergic and serotoninergic neurotransmitter systems. The present study investigated psychomotor differences in current and former recreational stimulant drug users compared with nonusing controls. Sixty participants comprised 3 groups: 20 current stimulant drug users (CSUs; 11 men, aged 31.4 ± 9.1 years), 20 former stimulant drug users (FSUs; 5 men, aged 39.1 ± 8.5 years), and 20 nonuser controls (NUCs; 5 men, aged 35.7 ± 6.4 years). Psychomotor arm steadiness for each participant was assessed with a wrist‐attached accelerometer during 5 arm positions with eyes open and then eyes closed. Arm‐drop of arm position was indicated by the arm longitudinal rotation axis (ALoRA), and tremor was indicated by the overall vector of dynamic body acceleration (VeDBA). Overall, CSUs performed the most poorly on ALoRA (P < .05) and VeDBA indices (P < .05), and FSUs perform almost as poorly on VeDBA indices (P < .05) compared with NUCs. It was concluded that stimulant drug use, primarily MDMA and amphetamines, may result in acute stimulant‐induced tremor as well as long‐term proprioceptive deficits in terms of arm‐droop.
- 19 April 2017
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 57 (10) , 1330-1337
Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants
The recreational use of various stimulant drugs has been implicated in the development of movement disorders through dysregulation of the dopaminergic and serotoninergic neurotransmitter systems. The present study investigated psychomotor differences in current and former recreational stimulant drug users compared with nonusing controls. Sixty participants comprised 3 groups: 20 current stimulant drug users (CSUs; 11 men, aged 31.4 ± 9.1 years), 20 former stimulant drug users (FSUs; 5 men, aged 39.1 ± 8.5 years), and 20 nonuser controls (NUCs; 5 men, aged 35.7 ± 6.4 years). Psychomotor arm steadiness for each participant was assessed with a wrist‐attached accelerometer during 5 arm positions with eyes open and then eyes closed. Arm‐drop of arm position was indicated by the arm longitudinal rotation axis (ALoRA), and tremor was indicated by the overall vector of dynamic body acceleration (VeDBA). Overall, CSUs performed the most poorly on ALoRA (P < .05) and VeDBA indices (P < .05), and FSUs perform almost as poorly on VeDBA indices (P < .05) compared with NUCs. It was concluded that stimulant drug use, primarily MDMA and amphetamines, may result in acute stimulant‐induced tremor as well as long‐term proprioceptive deficits in terms of arm‐droop.
- Open Access
- 21 June 2016
- Published by Herald Scholarly Open Access in Alcoholism, Drug Abuse and Substance Dependence
- Vol. 2 (1) , 1-2
Alcohol: Drink Less and Live More
Herald Scholarly Open Access publishes peer-reviewed scientific research which provides an immediate free access to articles. Herald Scholarly Open Access is publishing articles in 47 peer-reviewed Open Access journals in Biology, Medicine and Clinical sciences.
- 21 June 2016
- Published by Herald Scholarly Open Access in Alcoholism, Drug Abuse and Substance Dependence
- Vol. 2 (1) , 1-2
Open AccessAlcohol: Drink Less and Live More
Herald Scholarly Open Access publishes peer-reviewed scientific research which provides an immediate free access to articles. Herald Scholarly Open Access is publishing articles in 47 peer-reviewed Open Access journals in Biology, Medicine and Clinical sciences.
- Open Access
- 1 March 2016
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 54, 22-28
Motor delays in MDMA (ecstasy) exposed infants persist to 2 years
- 1 March 2016
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 54, 22-28
Open AccessMotor delays in MDMA (ecstasy) exposed infants persist to 2 years
- 28 July 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (4) , 272-275
Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study
Aims: Previous studies have shown increased sexual risk‐taking in experienced MDMA/ecstasy users. The main objectives of this study were to compare levels of sexual risk‐taking between a young student sample of predominantly heterosexual MDMA users and alcohol‐drinker controls and investigate potential gender differences.Methods: Recreational drug use and sexual risk questionnaires were completed by 20 MDMA users (10 females, 10 males) and 20 non‐user controls (10 females, 10 males). They were predominantly university students, aged between 20–22 years, mainly heterosexual (n = 37), with three bisexual participants.Results: MDMA users displayed significantly greater levels of sexual risk‐taking than the alcohol‐drinker controls. It involved significantly higher rates of casual sex, non‐condom use during sex, and penetrative sexual risks. This increase in sexual riskiness occurred to a similar extent in males and females.Conclusions: These findings indicate that both female and male ecstasy/MDMA users reported more risky sexual behaviours, than the non‐user controls. Further research into the sexual behaviour and sexual risk‐taking of heterosexual MDMA users should be conducted because much of the past literature has focused on homosexual participants. Copyright © 2015 John Wiley & Sons, Ltd.
- 28 July 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (4) , 272-275
Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study
Aims: Previous studies have shown increased sexual risk‐taking in experienced MDMA/ecstasy users. The main objectives of this study were to compare levels of sexual risk‐taking between a young student sample of predominantly heterosexual MDMA users and alcohol‐drinker controls and investigate potential gender differences.Methods: Recreational drug use and sexual risk questionnaires were completed by 20 MDMA users (10 females, 10 males) and 20 non‐user controls (10 females, 10 males). They were predominantly university students, aged between 20–22 years, mainly heterosexual (n = 37), with three bisexual participants.Results: MDMA users displayed significantly greater levels of sexual risk‐taking than the alcohol‐drinker controls. It involved significantly higher rates of casual sex, non‐condom use during sex, and penetrative sexual risks. This increase in sexual riskiness occurred to a similar extent in males and females.Conclusions: These findings indicate that both female and male ecstasy/MDMA users reported more risky sexual behaviours, than the non‐user controls. Further research into the sexual behaviour and sexual risk‐taking of heterosexual MDMA users should be conducted because much of the past literature has focused on homosexual participants. Copyright © 2015 John Wiley & Sons, Ltd.
- 28 July 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (4) , 213-224
Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation
Aims: Stimulant drugs such as nicotine and Ecstasy/3, 4‐methylenedioxymethamphetamine (MDMA) are taken for positive reasons, yet their regular use leads to deficits rather than gains. This article outlines the psychobiological rationale for this paradox.Methods: The empirical literature on nicotine, cocaine, amphetamine, Ecstasy/MDMA, and mephedrone are reviewed. A theoretical explanation for why they are problematic to humans is then described.Results: The acute effects of central nervous system (CNS) stimulants are typically positive, with greater alertness and emotional intensity. However, in the post‐drug recovery period, the opposite feelings develop, with lethargy and low moods. All recreational stimulants cause mood fluctuation, although it is most pronounced in drugs with rapid onset and comedown (e.g. nicotine and cocaine), explaining why they are the most addictive. Parallel fluctuations occur across many psychological and neurocognitive functions, with users suffering various off‐drug deficits. CNS stimulants also affect the hypothalamic–pituitary–adrenal axis, impairing sleep, disrupting homeostasis, and exacerbating psychiatric distress. Neuroimaging studies reveal altered brain activity patterns in regular users. These problems are related to lifetime usage but commence in novice users.Conclusions: Repetitive CNS stimulation is potentially damaging to the organism, both acutely and chronically. The review describes the various psychobiological systems through which recreational stimulant drugs impair human well‐being. Copyright © 2015 John Wiley & Sons, Ltd.
- 28 July 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (4) , 213-224
Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation
Aims: Stimulant drugs such as nicotine and Ecstasy/3, 4‐methylenedioxymethamphetamine (MDMA) are taken for positive reasons, yet their regular use leads to deficits rather than gains. This article outlines the psychobiological rationale for this paradox.Methods: The empirical literature on nicotine, cocaine, amphetamine, Ecstasy/MDMA, and mephedrone are reviewed. A theoretical explanation for why they are problematic to humans is then described.Results: The acute effects of central nervous system (CNS) stimulants are typically positive, with greater alertness and emotional intensity. However, in the post‐drug recovery period, the opposite feelings develop, with lethargy and low moods. All recreational stimulants cause mood fluctuation, although it is most pronounced in drugs with rapid onset and comedown (e.g. nicotine and cocaine), explaining why they are the most addictive. Parallel fluctuations occur across many psychological and neurocognitive functions, with users suffering various off‐drug deficits. CNS stimulants also affect the hypothalamic–pituitary–adrenal axis, impairing sleep, disrupting homeostasis, and exacerbating psychiatric distress. Neuroimaging studies reveal altered brain activity patterns in regular users. These problems are related to lifetime usage but commence in novice users.Conclusions: Repetitive CNS stimulation is potentially damaging to the organism, both acutely and chronically. The review describes the various psychobiological systems through which recreational stimulant drugs impair human well‐being. Copyright © 2015 John Wiley & Sons, Ltd.
- 21 April 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (3) , 199-207
Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits
Objectives: The goals of this study were to measure the neurocognitive performance of recent users of recreational Ecstasy and investigate whether it was associated with the stress hormone cortisol.Methods: The 101 participants included 27 recent light users of Ecstasy (one to four times in the last 3 months), 23 recent heavier Ecstasy users (five or more times) and 51 non‐users. Rivermead paragraph recall provided an objective measure for immediate and delayed recall. The prospective and retrospective memory questionnaire provided a subjective index of memory deficits. Cortisol levels were taken from near‐scalp 3‐month hair samples.Results: Cortisol was significantly raised in recent heavy Ecstasy users compared with controls, whereas hair cortisol in light Ecstasy users was not raised. Both Ecstasy groups were significantly impaired on the Rivermead delayed word recall, and both groups reported significantly more retrospective and prospective memory problems. Stepwise regression confirmed that lifetime Ecstasy predicted the extent of these memory deficits.Conclusions: Recreational Ecstasy is associated with increased levels of the bio‐energetic stress hormone cortisol and significant memory impairments. No significant relationship between cortisol and the cognitive deficits was observed. Ecstasy users did display evidence of a metacognitive deficit, with the strength of the correlations between objective and subjective memory performances being significantly lower in the Ecstasy users. Copyright © 2015 John Wiley & Sons, Ltd.
- 21 April 2015
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 30 (3) , 199-207
Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits
Objectives: The goals of this study were to measure the neurocognitive performance of recent users of recreational Ecstasy and investigate whether it was associated with the stress hormone cortisol.Methods: The 101 participants included 27 recent light users of Ecstasy (one to four times in the last 3 months), 23 recent heavier Ecstasy users (five or more times) and 51 non‐users. Rivermead paragraph recall provided an objective measure for immediate and delayed recall. The prospective and retrospective memory questionnaire provided a subjective index of memory deficits. Cortisol levels were taken from near‐scalp 3‐month hair samples.Results: Cortisol was significantly raised in recent heavy Ecstasy users compared with controls, whereas hair cortisol in light Ecstasy users was not raised. Both Ecstasy groups were significantly impaired on the Rivermead delayed word recall, and both groups reported significantly more retrospective and prospective memory problems. Stepwise regression confirmed that lifetime Ecstasy predicted the extent of these memory deficits.Conclusions: Recreational Ecstasy is associated with increased levels of the bio‐energetic stress hormone cortisol and significant memory impairments. No significant relationship between cortisol and the cognitive deficits was observed. Ecstasy users did display evidence of a metacognitive deficit, with the strength of the correlations between objective and subjective memory performances being significantly lower in the Ecstasy users. Copyright © 2015 John Wiley & Sons, Ltd.